U.S. FDA

• Sale of over-the-counter birth control pill backed by U.S. FDA panel

  FDA health advisers say a decades-old birth control pill should be sold without a prescription, paving the way for a likely U.S. approval of the 1st over-the-counter contraceptive.

  Health

  May 11, 2023
  
• U.S. FDA advisors back bivalent COVID vaccine for initial series, boosters

  Advisers to the U.S. Food and Drug Administration on Thursday unanimously voted in favor of targeting the same coronavirus strain for initial COVID-19 vaccine doses and boosters.

  Health

  Jan 26, 2023
  
• Advertisement
• U.S. FDA allows over-the-counter hearing aids in ‘milestone’ regulation

  The U.S. regulator said the new regulation cuts red tape by creating a new class of hearing aids that don't require a medical exam, a prescription and other specialty evaluations.

  Health

  Aug 16, 2022
• Advertisement
• Why Novavax vaccine may be an option for U.S. troops who refused other shots 

  The Novavax vaccine may be an acceptable option for some of the 27,000 service members who have sought religious exemptions from the mandatory vaccine.

  Health

  Jun 9, 2022
• U.S. FDA issues plan to ban menthol cigarettes, flavoured cigars

  Menthol cigarettes, banned in many states including California and Massachusetts, account for more than a third of the industry's overall market share in the United States.

  Health

  Apr 28, 2022
• Pfizer seeks U.S. approval of COVID-19 booster for children aged 5-11

  Pfizer and BioNTech have filed for the clearance of a 10-microgram booster dose for children 5 to 11 years.

  Health

  Apr 26, 2022
• U.S. gives full approval to 1st COVID-19 drug for young children

  The U.S. drug regulator on Monday granted the first full approval for treating COVID-19 in children aged 28 days and older to Gilead Sciences Inc's GILD.O drug remdesivir.

  Health

  Apr 25, 2022
• New COVID-19 breath test approved in U.S. Here’s how it could be useful

  A non-invasive devise using breath samples can test for COVID-19 in three minutes, but experts say there is a trade-off to the convenience and speed.

  Health

  Apr 16, 2022
• Advertisement
• U.S. FDA panel backs booster shot for Johnson & Johnson COVID-19 vaccine

  FDA's reviewers found no new safety concerns after a second dose of J&J against COVID-19, but they cautioned about the small number of patients studied and short follow-up period.

  Health

  Oct 15, 2021